Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2021-05-03 2021-05-03
Drug Identification Number 02358913 02358913
Brand name SANDOZ OLOPATADINE SANDOZ OLOPATADINE
Common or Proper name SANDOZ OLOPATADINE SANDOZ OLOPATADINE
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients OLOPATADINE OLOPATADINE
Strength(s) 0.1% 0.1%
Dosage form(s) SOLUTION SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC OPHTHALMIC OPHTHALMIC
Packaging size 5ML LDP V1 CA 5ML LDP V1 CA
ATC code S01GX S01GX
ATC description DECONGESTANTS AND ANTIALLERGICS DECONGESTANTS AND ANTIALLERGICS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2021-04-23 2021-04-23
Estimated end date 2021-04-30 2021-04-30
Actual end date 2021-04-30 2021-04-30
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments